169 related articles for article (PubMed ID: 6181328)
21. Effects of flurbiprofen on myocardial cell damage in acute myocardial ischemia.
Smith EF; Carrow BA; Lefer AM
Res Commun Chem Pathol Pharmacol; 1980 Jun; 28(3):413-33. PubMed ID: 7403657
[TBL] [Abstract][Full Text] [Related]
22. The action of non-steroidal antiinflammatory agents on platelet aggregation and vessel tone in relation to inhibition of PGI2- and thromboxane-release. With particular reference to 5-benzoyl-alpha-methyl-2-thiophene acetic acid (tiaprofenic acid).
Kuhn A; Sauerland S; Schiffer K; Schrör K
Arzneimittelforschung; 1980; 30(9):1538-42. PubMed ID: 7006618
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of epinephrine-exacerbated coronary thrombus formation by prostacyclin in the dog.
Bertha BG; Folts JD
J Lab Clin Med; 1984 Feb; 103(2):204-14. PubMed ID: 6363581
[TBL] [Abstract][Full Text] [Related]
24. Epoprostenol (PGI2) prevents postischemic ventricular fibrillation and improves outcome in a canine model of sudden death.
Jouve R; Puddu PE; Langlet F; Guillen JC; Gautier T; Cano JP; Serradimigni A
J Pharmacol; 1985; 16(2):139-57. PubMed ID: 3903352
[TBL] [Abstract][Full Text] [Related]
25. Antifibrillatory action of the stable orally active prostacyclin analogues iloprost and ZK 96 480 in rats after coronary artery ligation.
Müller B; Maass B; Stürzebecher S; Skuballa W
Biomed Biochim Acta; 1984; 43(8-9):S175-8. PubMed ID: 6083785
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory effects of ZK 36374, a stable prostacyclin analogue, on adhesion of rabbit platelets to damaged aorta and serotonin release by adherent platelets.
Menys VC; Davies JA
Clin Sci (Lond); 1983 Aug; 65(2):149-53. PubMed ID: 6190604
[TBL] [Abstract][Full Text] [Related]
27. Reduction in infarct size by the prostacyclin analogue iloprost (ZK 36374) after experimental coronary artery occlusion-reperfusion.
Chiariello M; Golino P; Cappelli-Bigazzi M; Ambrosio G; Tritto I; Salvatore M
Am Heart J; 1988 Mar; 115(3):499-504. PubMed ID: 2449815
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of platelet aggregation and antagonism of vasopressin-induced ECG changes in primates by a carboprostacyclin analogue, ZK 36374.
Adaikan PG; Karim SM; Lau LC; Tai MY; Kottegoda SR
Thromb Res; 1984 Feb; 33(3):333-40. PubMed ID: 6200948
[TBL] [Abstract][Full Text] [Related]
29. Permissive effect of molsidomine towards cardioprotective action of iloprost in myocardial ischemia in cats.
Gryglewski RJ; Swies J; Chłopicki S; Niezabitowski P
J Physiol Pharmacol; 1993 Sep; 44(3):313-8. PubMed ID: 7694690
[TBL] [Abstract][Full Text] [Related]
30. A 15-nonstereogenic carbocyclic analogue of prostacyclin: effects on human platelets and uterine artery.
Kobzar G; Shelkovnikov S; Mardla V; Savitski G; Lopp M; Kanger T; Lille U
J Lipid Mediat Cell Signal; 1994 Sep; 10(3):243-9. PubMed ID: 7812675
[TBL] [Abstract][Full Text] [Related]
31. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
[TBL] [Abstract][Full Text] [Related]
32. A new prostacyclin analog, KP-10614, inhibits platelet-polymorphonuclear leukocyte interaction and limits experimental infarct size in rat heart.
Kanayama T; Kimura Y; Mizogami S
J Pharmacol Exp Ther; 1993 Jul; 266(1):344-9. PubMed ID: 7687292
[TBL] [Abstract][Full Text] [Related]
33. Antagonism of platelet aggregation by 13-azaprostanoic acid in acute myocardial ischemia and sudden death.
Burke SE; Roth DM; Lefer AM
Thromb Res; 1983 Mar; 29(5):473-88. PubMed ID: 6857596
[TBL] [Abstract][Full Text] [Related]
34. Carbacyclin--a potent stable prostacyclin analogue for the inhibition of platelet aggregation.
Whittle BJ; Moncada S; Whiting F; Vane JR
Prostaglandins; 1980 Apr; 19(4):605-27. PubMed ID: 6992234
[TBL] [Abstract][Full Text] [Related]
35. Anti-ischemic actions of a new thromboxane receptor antagonist during acute myocardial ischemia in cats.
Brezinski ME; Yanagisawa A; Darius H; Lefer AM
Am Heart J; 1985 Dec; 110(6):1161-7. PubMed ID: 3000159
[TBL] [Abstract][Full Text] [Related]
36. Protection of the ischemic myocardium from reperfusion injury by prostaglandin E1 inhibition of ischemia-induced neutrophil activation.
Schrör K; Thiemermann C; Ney P
Naunyn Schmiedebergs Arch Pharmacol; 1988 Sep; 338(3):268-74. PubMed ID: 2848205
[TBL] [Abstract][Full Text] [Related]
37. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
Smith JB; Araki H; Lefer AM
Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
[TBL] [Abstract][Full Text] [Related]
38. Comparison in anesthetized dogs of the anti-aggregatory and hemodynamic effects of prostacyclin and a chemically stable prostacyclin analog, 6a-carba-PGI2 (carbacyclin).
Aiken JW; Shebuski RJ
Prostaglandins; 1980 Apr; 19(4):629-43. PubMed ID: 6992235
[TBL] [Abstract][Full Text] [Related]
39. Dissociation of the anti-ischaemic effects of cloricromene from its anti-platelet activity.
Lidbury PS; Cirillo R; Vane JR
Br J Pharmacol; 1993 Sep; 110(1):275-80. PubMed ID: 8220889
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological evaluation of 5-(Z,E)-13,14-didehydro-20-methyl-carboprostacyclin (FCE 22509).
Ceserani R; Grossoni M; Ukmar G; Colombo M; Mongelli N
Prostaglandins Leukot Med; 1986 Mar; 21(3):231-45. PubMed ID: 3517883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
